Stage 4S neuroblastoma, a disseminated tumor with excellent outcome

Saudi Medical Journal

Volumn 27, Issue 11, 2006, Pages 1734-1736

  Elimam, Najla A ^a   Atra, Ayad A ^a   Fayea, Najwa Y ^a   Al Asaad, Tareq G ^a   Khattab, Taha M ^a   Al Sulami, Ganadeel A ^a   Felimban, Sami K ^a   Felimban, S ^a  

^a King Abdul Aziz Medical City   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CAV PROTOCOL;

ABDOMINAL MASS; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED CANCER; DRUG RESPONSE; FEMALE; FOLLOW UP; HEPATOMEGALY; HUMAN; INFANT; LIVER METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; OUTCOMES RESEARCH; PROGNOSIS; REMISSION; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; REVIEW; SAUDI ARABIA; SKIN METASTASIS; TUMOR BIOPSY; ADRENAL GLAND; ADRENAL TUMOR; AGE; ARTICLE; BIOPSY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; METASTASIS; MORTALITY; NEWBORN; PATHOLOGY; RADIOGRAPHY; SKIN; SKIN TUMOR; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR REGRESSION;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; AGE FACTORS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HEPATOMEGALY; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; NEOPLASM REGRESSION, SPONTANEOUS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SAUDI ARABIA; SKIN; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VINCRISTINE;

EID: 39049180612     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the International criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-1477.
2. De Bernardi B, Pianca C, Boni L, Brisigotti M, Carli M, Bagnulo S, et al. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer 1992; 15: 1625-1633.
3. Guglielmi M, De Bernardi B, Rizzo A, Federici S, Boglino C, Siracusa F, et al. Resection of primary Tumor in stage IV-S neuroblastoma: Does it affect the clinical course? J Clin Oncol 1996; 14: 1537-1544.
4. Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study. J Clin Oncol 2000; 18: 477-486.
5. Mancini AF, Rosito P, Vitelli A, Paolucci P, Vecchi V, Paulucci G, et al. IV-s neuroblastoma: A cooperative study of 30 children. Med Pediatr Oncol 1984; 12: 155-161.
6. Schleiermacher G, Rubie H, Hartmann O, Bergeron C, Chastagner P, Mechinaud F, et al. For the Neuroblastoma Study Group of the French Society of Pediatric Oncology. Treatment of stage 4s neuroblastoma - report of 10 year's experience of the French Society of Paediatric Oncology (SFOP). Br J Cancer 2003; 89: 470-476.
7. Hsu LL, Evans AE, D'Angio GJ. Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate. Med Pediatr Oncol 1996; 27: 521-528.
8. Strother D, Shuster JJ, Mc Williams N, Nitschke R, Smith EI, Joshi VJ, et al. Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma. J Pediatr Hematol Oncol 1995; 17: 254-259.
9. Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, et al. Prognostic significance of age. MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The Pediatric Oncology Group experience - A Pediatric Oncology Group study. J Clin Oncol 1998; 16: 2007-2017.
10. Martinerz DA, King DR, Ginn-Pease ME, Haase GM, Wiener ES. Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: An analysis of 37 patients. J Pediatr Surgery 1992; 27: 1016-1020.